VBI Total Current Liabilities vs Other Current Assets Analysis

VBIV Stock

USD 0.61 0.01 1.67%

VBI Vaccines financial indicator trend analysis is much more than just breaking down VBI Vaccines prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether VBI Vaccines is a good investment. Please check the relationship between VBI Vaccines Total Current Liabilities and its Other Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.

Total Current Liabilities vs Other Current Assets

Total Current Liabilities vs Other Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of VBI Vaccines Total Current Liabilities account and Other Current Assets. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between VBI Vaccines' Total Current Liabilities and Other Current Assets is 0.55. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of VBI Vaccines, assuming nothing else is changed. The correlation between historical values of VBI Vaccines' Total Current Liabilities and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of VBI Vaccines are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Total Current Liabilities i.e., VBI Vaccines' Total Current Liabilities and Other Current Assets go up and down completely randomly.

Correlation Coefficient

0.55

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on VBI Vaccines balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of VBI Vaccines are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Most indicators from VBI Vaccines' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into VBI Vaccines current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VBI Vaccines. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.At this time, VBI Vaccines' Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to climb to about 35.9 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (0.76) in 2024.

	2023	2024 (projected)
Non Recurring	5.7M	5.0M
Reconciled Depreciation	2.0M	1.6M

Non Recurring Reconciled Depreciation

VBI Vaccines fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Total Current Liabilities	Accounts Payable	Net Receivables	Non Current Liabilities Total	Short Term Investments	Other Assets	Short Long Term Debt Total	Inventory	Other Current Liab	Short Term Debt	Common Stock Total Equity
Total Assets		0.89	0.49	-0.66	-0.06	0.72	0.83	0.49	0.74	-0.06	0.09	0.45	0.23	0.5	0.72	-0.11	0.12	-0.14	0.55	0.34	0.46	0.14	-0.15	0.39	-0.42	0.55
Total Stockholder Equity	0.89		0.59	-0.73	0.36	0.55	0.79	0.25	0.62	-0.42	-0.28	0.32	-0.24	0.6	0.56	-0.49	-0.28	-0.35	0.27	0.48	0.3	-0.21	-0.51	0.06	-0.63	0.17
Property Plant And Equipment Net	0.49	0.59		0.04	0.4	-0.19	0.84	-0.16	-0.14	-0.34	-0.3	0.54	-0.19	0.97	-0.18	-0.36	-0.35	0.18	0.19	0.16	-0.44	0.16	-0.28	-0.41	-0.25	-0.08
Net Debt	-0.66	-0.73	0.04		-0.21	-0.81	-0.28	-0.38	-0.84	0.32	0.19	0.0	0.16	0.05	-0.8	0.4	0.15	0.62	-0.29	-0.44	-0.72	0.49	0.53	-0.42	0.68	-0.19
Retained Earnings	-0.06	0.36	0.4	-0.21		-0.33	0.21	-0.51	-0.29	-0.95	-0.73	-0.09	-0.89	0.32	-0.36	-0.94	-0.82	-0.54	-0.21	0.12	-0.29	-0.73	-0.91	-0.61	-0.67	-0.81
Cash	0.72	0.55	-0.19	-0.81	-0.33		0.22	0.73	0.97	0.19	0.27	-0.02	0.33	-0.14	0.97	0.12	0.33	-0.34	0.41	0.22	0.78	0.03	0.02	0.75	-0.32	0.61
Non Current Assets Total	0.83	0.79	0.84	-0.28	0.21	0.22		0.1	0.23	-0.28	-0.1	0.59	0.07	0.8	0.2	-0.24	-0.1	0.04	0.45	0.13	-0.03	0.19	-0.26	-0.02	-0.35	0.23
Non Currrent Assets Other	0.49	0.25	-0.16	-0.38	-0.51	0.73	0.1		0.69	0.37	0.66	-0.04	0.47	-0.04	0.73	0.25	0.56	-0.24	0.5	0.1	0.57	0.37	0.32	0.82	-0.18	0.7
Cash And Short Term Investments	0.74	0.62	-0.14	-0.84	-0.29	0.97	0.23	0.69		0.18	0.21	0.05	0.25	-0.07	0.99	0.06	0.27	-0.32	0.35	0.44	0.8	-0.04	-0.01	0.66	-0.34	0.6
Common Stock Shares Outstanding	-0.06	-0.42	-0.34	0.32	-0.95	0.19	-0.28	0.37	0.18		0.58	0.06	0.79	-0.27	0.25	0.93	0.66	0.65	0.07	-0.03	0.13	0.7	0.93	0.42	0.79	0.7
Other Current Assets	0.09	-0.28	-0.3	0.19	-0.73	0.27	-0.1	0.66	0.21	0.58		0.06	0.76	-0.23	0.3	0.55	0.92	0.15	0.56	-0.18	0.39	0.66	0.71	0.63	0.21	0.61
Other Stockholder Equity	0.45	0.32	0.54	0.0	-0.09	-0.02	0.59	-0.04	0.05	0.06	0.06		0.28	0.54	0.06	0.13	0.1	0.53	0.26	0.28	-0.13	0.4	0.04	-0.02	0.07	0.26
Total Liab	0.23	-0.24	-0.19	0.16	-0.89	0.33	0.07	0.47	0.25	0.79	0.76	0.28		-0.19	0.32	0.83	0.85	0.49	0.55	-0.29	0.3	0.76	0.78	0.65	0.49	0.77
Property Plant And Equipment Gross	0.5	0.6	0.97	0.05	0.32	-0.14	0.8	-0.04	-0.07	-0.27	-0.23	0.54	-0.19		-0.11	-0.3	-0.3	0.21	0.1	0.23	-0.44	0.25	-0.19	-0.37	-0.21	-0.01
Total Current Assets	0.72	0.56	-0.18	-0.8	-0.36	0.97	0.2	0.73	0.99	0.25	0.3	0.06	0.32	-0.11		0.12	0.35	-0.28	0.39	0.43	0.83	0.02	0.06	0.71	-0.29	0.67
Total Current Liabilities	-0.11	-0.49	-0.36	0.4	-0.94	0.12	-0.24	0.25	0.06	0.93	0.55	0.13	0.83	-0.3	0.12		0.69	0.72	0.0	-0.26	0.04	0.75	0.91	0.41	0.84	0.64
Accounts Payable	0.12	-0.28	-0.35	0.15	-0.82	0.33	-0.1	0.56	0.27	0.66	0.92	0.1	0.85	-0.3	0.35	0.69		0.24	0.51	-0.18	0.43	0.66	0.74	0.69	0.3	0.68
Net Receivables	-0.14	-0.35	0.18	0.62	-0.54	-0.34	0.04	-0.24	-0.32	0.65	0.15	0.53	0.49	0.21	-0.28	0.72	0.24		-0.2	-0.05	-0.47	0.7	0.67	-0.2	0.84	0.3
Non Current Liabilities Total	0.55	0.27	0.19	-0.29	-0.21	0.41	0.45	0.5	0.35	0.07	0.56	0.26	0.55	0.1	0.39	0.0	0.51	-0.2		-0.1	0.47	0.26	0.08	0.55	-0.35	0.44
Short Term Investments	0.34	0.48	0.16	-0.44	0.12	0.22	0.13	0.1	0.44	-0.03	-0.18	0.28	-0.29	0.23	0.43	-0.26	-0.18	-0.05	-0.1		0.33	-0.31	-0.19	-0.1	-0.23	0.13
Other Assets	0.46	0.3	-0.44	-0.72	-0.29	0.78	-0.03	0.57	0.8	0.13	0.39	-0.13	0.3	-0.44	0.83	0.04	0.43	-0.47	0.47	0.33		-0.21	0.0	0.72	-0.35	0.47
Short Long Term Debt Total	0.14	-0.21	0.16	0.49	-0.73	0.03	0.19	0.37	-0.04	0.7	0.66	0.4	0.76	0.25	0.02	0.75	0.66	0.7	0.26	-0.31	-0.21		0.82	0.29	0.59	0.59
Inventory	-0.15	-0.51	-0.28	0.53	-0.91	0.02	-0.26	0.32	-0.01	0.93	0.71	0.04	0.78	-0.19	0.06	0.91	0.74	0.67	0.08	-0.19	0.0	0.82		0.31	0.79	0.61
Other Current Liab	0.39	0.06	-0.41	-0.42	-0.61	0.75	-0.02	0.82	0.66	0.42	0.63	-0.02	0.65	-0.37	0.71	0.41	0.69	-0.2	0.55	-0.1	0.72	0.29	0.31		-0.08	0.7
Short Term Debt	-0.42	-0.63	-0.25	0.68	-0.67	-0.32	-0.35	-0.18	-0.34	0.79	0.21	0.07	0.49	-0.21	-0.29	0.84	0.3	0.84	-0.35	-0.23	-0.35	0.59	0.79	-0.08		0.26
Common Stock Total Equity	0.55	0.17	-0.08	-0.19	-0.81	0.61	0.23	0.7	0.6	0.7	0.61	0.26	0.77	-0.01	0.67	0.64	0.68	0.3	0.44	0.13	0.47	0.59	0.61	0.7	0.26

Click cells to compare fundamentals

VBI Vaccines Account Relationship Matchups

VBI Vaccines fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	122.2M	209.4M	210.3M	155.1M	87.0M	73.5M
Total Stockholder Equity	88.3M	171.7M	143.9M	64.2M	7.5M	7.2M
Property Plant And Equipment Net	10.2M	10.7M	11.0M	12.3M	11.9M	21.9M
Net Debt	(29.4M)	(92.9M)	(89.9M)	(10.4M)	29.4M	30.8M
Retained Earnings	(262.4M)	(308.6M)	(378.4M)	(489.6M)	(582.4M)	(553.3M)
Cash	44.2M	93.8M	121.7M	62.6M	23.7M	28.9M
Non Current Assets Total	75.2M	77.3M	80.0M	77.4M	50.7M	42.9M
Non Currrent Assets Other	2.1M	2.2M	4.6M	4.7M	1.2M	992.6K
Cash And Short Term Investments	44.2M	119.1M	121.7M	62.6M	23.7M	31.5M
Common Stock Shares Outstanding	4.0M	7.3M	8.5M	8.6M	15.6M	16.4M
Liabilities And Stockholders Equity	122.2M	209.4M	210.3M	155.1M	87.0M	73.5M
Other Current Assets	450K	1.3M	2.2M	8.4M	2.8M	2.9M
Other Stockholder Equity	66.4M	75.5M	81.6M	90.0M	107.4M	112.8M
Total Liab	33.9M	37.7M	66.4M	90.9M	79.4M	83.4M
Property Plant And Equipment Gross	11.7M	12.3M	19.3M	23.6M	22.3M	27.7M
Total Current Assets	47.0M	132.0M	130.3M	77.7M	36.2M	33.0M
Total Current Liabilities	29.8M	17.3M	32.6M	36.9M	75.7M	79.5M
Accounts Payable	1.1M	3.7M	4.3M	13.0M	6.4M	6.8M
Net Receivables	201K	77K	8K	94K	1.3M	1.3M
Non Current Liabilities Total	4.2M	20.3M	33.8M	54.0M	3.7M	3.5M
Accumulated Other Comprehensive Income	(752K)	1.3M	(1.6M)	21.4M	28.3M	29.7M
Other Assets	620K	2.2M	1.3M	1.4M	1.0	0.95
Short Long Term Debt Total	14.8M	944K	31.8M	52.2M	53.0M	55.7M
Inventory	1.1M	2.2M	2.6M	6.6M	8.5M	8.9M
Other Current Liab	12.9M	12.4M	26.9M	22.6M	6.7M	5.7M
Short Term Debt	14.8M	944K	839K	972K	51.7M	54.3M
Common Stock Total Equity	285.0M	403.5M	442.2M	442.3M	508.7M	260.5M
Common Stock	285.0M	403.5M	442.2M	442.3M	454.2M	247.1M
Net Tangible Assets	25.3M	107.3M	79.5M	3.7M	4.2M	4.0M
Current Deferred Revenue	882K	255K	526K	409K	10.9M	11.4M
Intangible Assets	60.8M	62.2M	62.1M	58.3M	36.5M	47.5M
Property Plant Equipment	11.7M	10.7M	11.0M	12.3M	14.1M	14.8M
Other Liab	3.4M	3.4M	2.9M	2.7M	3.1M	2.7M
Short Long Term Debt	1.6M	1.1M	14.8M	50.8M	58.4M	61.3M
Capital Surpluse	66.4M	75.5M	81.6M	90.0M	103.5M	75.2M
Good Will	8.3M	2.2M	2.3M	2.1M	1.1M	1.1M
Retained Earnings Total Equity	(262.4M)	(308.6M)	(378.4M)	(489.6M)	(440.6M)	(418.6M)

Pair Trading with VBI Vaccines

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.

The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for VBI Stock Analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

VBI Total Current Liabilities vs Other Current Assets Analysis

Total Current Liabilities vs Other Current Assets

Total Current Liabilities vs Other Current Assets Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Other Current Assets

VBI Vaccines fundamental ratios Correlations

VBI Vaccines Account Relationship Matchups

High Positive Relationship

High Negative Relationship

VBI Vaccines fundamental ratios Accounts

Pair Trading with VBI Vaccines

Additional Tools for VBI Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.99	Cash And Short Term Investments
Property Plant And Equipment Gross	+ 0.97	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash
Total Current Liabilities	+ 0.93	Common Stock Shares Outstanding
Inventory	+ 0.93	Common Stock Shares Outstanding

Common Stock Shares Outstanding	- 0.95	Retained Earnings
Total Current Liabilities	- 0.94	Retained Earnings
Inventory	- 0.91	Retained Earnings
Total Liab	- 0.89	Retained Earnings
Cash And Short Term Investments	- 0.84	Net Debt
Accounts Payable	- 0.82	Retained Earnings